EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Open Access · CC BY-NC 4.0

Metformin Pharmacogenetics in Heart Failure Patients with Reduced Ejection Fraction: Impact on Metformin and Growth Differentiation Factor-15 Plasma Levels

Anders Hostrup Larsen, Tore Bjerregaard Stage, Mette Marie Hougaard Christensen, Søren Feddersen, Flemming Nielsen, Helene Nørrelund, Jørgen Frøkiær, Niels Jessen, Kim Brøsen, Henrik Wiggers

Clinical Pharmacokinetics · 2026-11 · 65 (11) · 1759-1770

DOI: 10.1007/s40262-026-01699-1 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 28.09.2026. Verfasst von Anders Hostrup Larsen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark. andershostrup@dadlnet.dk. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Heart Failure, Hypoglycemic Agents, Metformin. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Danish Diabetes and Endocrine Academy, Arvid Nilssons Fond, Sundhedsvidenskabelige Fakultet, Aarhus Universitet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: This study assessed plasma metformin trough steady-state concentrations and plasma growth differentiation factor-15 (GDF-15) in patients with heart failure with reduced ejection fraction (HFrEF), and evaluated the effect of genetic variations in OCT1, OCT2, MATE1, and MATE2-K on metformin trough levels and GDF-15 levels. METHODS: The study population comprised 109 HFrEF patients with type 2 diabetes on stable metformin treatment (median 1700 mg, range 500-3000) in an open-label design. Patients were genotyped for seven selected variants in OCT1, OCT2, MATE1 and MATE2-K. Plasma metformin trough measurements (288 samples) were obtained in triplicates with a median 7-day interval (interquartile range, 6-10 days). Plasma GDF-15 concentrations were measured once per patient. RESULTS: Mean dose-normalised metformin trough concentrations were 508 ng/L/g (range 68-3515) with substantial interpatient variation (intraclass correlation coefficient 0.79). Metformin trough levels were independent of genetic variants in OCT1 (p = 0.12), OCT2 (p = 0.10) and MATE1 (p = 0.95), after adjustment for estimated glomerular filtration rate (eGFR) and time since last tablet intake. MATE2-K was excluded due to insufficient variant frequency. Metformin dose correlated with trough concentrations (R2 = 0.36, p < 0.001), and metformin trough concentrations correlated with NT-proBNP levels (R2 = 0.31, p < 0.001) and with GDF-15 levels (R2 = 0.51, p < 0.001). GDF-15 levels were independent of genetic variants in OCT1, OCT2, and MATE1, after adjustment for eGFR and time since last tablet intake. CONCLUSIONS: In HFrEF patients, transporter genetic variants in OCT1, OCT2, and MATE1 did not influence metformin trough steady-state concentrations or circulating GDF-15 levels. Metformin trough levels display large (50-fold) interpatient variability and a dose-dependent relationship. CLINICAL TRIAL REGISTRATION: URL: https://clinicaltrials.gov . Unique identifier: NCT02797340.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Differentiation Factor 15Heart FailureHypoglycemic AgentsMetforminAgedFemaleHumansMaleMiddle AgedDiabetes Mellitus, Type 2GenotypeOrganic Cation Transport ProteinsOrganic Cation Transporter 1Organic Cation Transporter 2PharmacogeneticsStroke Volume

Substanzen

GDF15 protein, humanGrowth Differentiation Factor 15Hypoglycemic AgentsMetforminOrganic Cation Transport ProteinsOrganic Cation Transporter 1Organic Cation Transporter 2SLC22A2 protein, humanSLC47A1 protein, humanSLC47A2 protein, human

Autor:innen und Institutionen

  • Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark. andershostrup@dadlnet.dk.
  • Department of Cardiology, Gødstrup Hospital, Herning, Denmark. andershostrup@dadlnet.dk.
  • Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense M, Denmark.
  • Department of Clinical Pharmacology, Odense University Hospital, Odense M, Denmark.
  • Department of Clinical Biochemistry, Odense University Hospital, Odense C, Denmark.
  • Clinical Biochemistry, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Förderung

  • Danish Diabetes and Endocrine Academy
  • Arvid Nilssons Fond
  • Sundhedsvidenskabelige Fakultet, Aarhus Universitet
  • Hjerteforeningen
  • Augustinus Fonden
  • Aase og Ejnar Danielsens Fond
  • Helga og Peter Kornings Fond
  • Kirsten Anthonius Memorial Fund

Zitieren

APA

Larsen, A. H., Stage, T. B., Christensen, M. M. H., Feddersen, S., Nielsen, F., Nørrelund, H., Frøkiær, J., Jessen, N., Brøsen, K., & Wiggers, H. (2026). Metformin Pharmacogenetics in Heart Failure Patients with Reduced Ejection Fraction: Impact on Metformin and Growth Differentiation Factor-15 Plasma Levels. Clinical Pharmacokinetics, 65(11), 1759-1770. https://doi.org/10.1007/s40262-026-01699-1

Vancouver

Larsen AH, Stage TB, Christensen MMH, Feddersen S, Nielsen F, Nørrelund H, et al. Metformin Pharmacogenetics in Heart Failure Patients with Reduced Ejection Fraction: Impact on Metformin and Growth Differentiation Factor-15 Plasma Levels. Clinical Pharmacokinetics. 2026;65(11):1759-1770. doi:10.1007/s40262-026-01699-1

BibTeX
@article{Larsen2026,
  author = {Larsen, Anders Hostrup and Stage, Tore Bjerregaard and Christensen, Mette Marie Hougaard and Feddersen, Søren and Nielsen, Flemming and Nørrelund, Helene and Frøkiær, Jørgen and Jessen, Niels and Brøsen, Kim and Wiggers, Henrik},
  title = {Metformin Pharmacogenetics in Heart Failure Patients with Reduced Ejection Fraction: Impact on Metformin and Growth Differentiation Factor-15 Plasma Levels},
  journal = {Clinical Pharmacokinetics},
  year = {2026},
  volume = {65},
  number = {11},
  pages = {1759--1770},
  doi = {10.1007/s40262-026-01699-1}
}
Kostenlos starten →